Table 3.
Summary of different hypertension telemedicine studies.
Study | Study design | Assessed device/technique | Number of patients | End-points | Results |
---|---|---|---|---|---|
Wakefield et al. (39) | Randomized, controlled trial−3 treatment groups (high intensity vs. low intensity vs. usual care) | Home telehealth device (daily BP monitoring and differentiated questionnaire low vs. high intensity group) and nurse management | 302 | Primary outcome: SBP change | Positive for the high intensity group |
Hebert et al. (40) | Randomized, controlled trial−3 arms (nurse management vs. home monitoring vs. usual care) | Nurse counseling; Informing on strategies for controlling BP | 416 | Changes in SBP and DBP at 9 and 18 months | Positive for SBP in the nurse counseling group |
Pan et al. (41) | Randomized, controlled trial−2 arms | Home telemonitoring for blood pressure (delivered by a GP, a hypertension specialist, a nurse) | 198 | Change in SBP at 1, 3, and 6 months | Positive |
Margolis et al. (42) | Randomized, controlled trial−2 arms | Home BP monitoring and pharmacist management | 450 | Changes in SBP and DBP | Positive (for up to 24 months) |
McManus et al. (43) | Randomized, controlled trial−3 arms (self-monitoring vs. telemonitoring vs. usual care) | Self-monitoring with electronic sphygmomanometer vs. telemonitoring via phone messages | 1,003 | Change in SBP at 12 months | Positive in both intervention groups |
Mohsen et al. (44) | Randomized, controlled trial – 2 arms | Nurse counseling by follow-up phone calls | 100 | Changes in mean arterial pressure and body-mass index | Positive |